2023 ¿µ³²´ëÇб³º´¿ø Çѳ²ºñ´¢ÀÇÇÐ ¿¬¼ö°Á : 2023-11-18
±³À°ÀÏÀÚ : 2023-11-18
±³À°Àå¼Ò : ¿µ³²´ëÇб³ ÀÇ°ú´ëÇÐ °Àǵ¿ 1Ãþ Á×¼º°ÀǽÇ
±³À°ÁÖÁ¦ : 2023 ¿µ³²´ëÇб³º´¿ø Çѳ²ºñ´¢ÀÇÇÐ ¿¬¼ö°ÁÂ
ÁÖÃÖ±â°ü : ¿µ³²´ëÇб³º´¿ø
½ÃÇà±â°ü(ÁöºÎ/°ú) : ºñ´¢ÀÇÇаú
´ã´çÀÚ : ±è¿µ¿í
¿¬¶ôó : 010-9509-9174
À̸ÞÀÏ : jojo9174@hanmail.net
±³À°Á¾·ù : ºñ´¢ÀÇÇаú
Âü¼®¿¹»óÀÎ : 100¸í
Èñ¸ÁÆòÁ¡ : 5Á¡
Áö¿ª : ´ë±¸±¤¿ª½Ã
±³À°½Ã°£ : 5 ½Ã°£ 40ºÐ
¼¼ºÎ¼ö°·á : 0¿ø
ºñ°í
±¸ºÐ ¿ùÀÏ °ÀÇ½Ç ½Ã°£ ±³À°Á¦¸ñ °»ç¸í(¼Ò¼Ó) Çʼö°ú¸ñ
±³À°½Ã°£ 11¿ù 18ÀÏ ¿µ³²´ëÇб³ÀÇ°ú´ëÇÐ Á×¼º°ÀÇ½Ç 08:30~08:45 Pediatrics – Nocturnal Enuresis1. Management of treatment-resistant nocturnal enuresis Á¤ÇöÁø(´ë±¸°¡Å縯ÀÇ´ë)
±³À°½Ã°£ 11¿ù 18ÀÏ ¿µ³²´ëÇб³ÀÇ°ú´ëÇÐ Á×¼º°ÀÇ½Ç 08:45~09:00 2. Nocturnal enuresis after adolescent ±è¼ºÃ¶(¿ï»êÀÇ´ë)
Åä·Ð 11¿ù 18ÀÏ ¿µ³²´ëÇб³ÀÇ°ú´ëÇÐ Á×¼º°ÀÇ½Ç 09:00~09:15 Åä·Ð ±è¼±¿Á(Àü³²ÀÇ´ë)
±³À°½Ã°£ 11¿ù 18ÀÏ ¿µ³²´ëÇб³ÀÇ°ú´ëÇÐ Á×¼º°ÀÇ½Ç 09:15~09:30 Male andrology1. The recent update of ED management ¹Úµ¿Áø(µ¿±¹ÀÇ´ë)
±³À°½Ã°£ 11¿ù 18ÀÏ ¿µ³²´ëÇб³ÀÇ°ú´ëÇÐ Á×¼º°ÀÇ½Ç 09:30~09:45 2. Testosterone and cardiovascular disease: recent update ¾çÈñÁ¶(¼øõÇâÀÇ´ë)
Åä·Ð 11¿ù 18ÀÏ ¿µ³²´ëÇб³ÀÇ°ú´ëÇÐ Á×¼º°ÀÇ½Ç 09:45~10:00 Åä·Ð ½ÅÈ«¼®(´ë±¸°¡Å縯ÀÇ´ë)
ÈÞ½Ä 11¿ù 18ÀÏ ¿µ³²´ëÇб³ÀÇ°ú´ëÇÐ Á×¼º°ÀÇ½Ç 10:00~10:20 Coffee break ( )
±âŸ 11¿ù 18ÀÏ ¿µ³²´ëÇб³ÀÇ°ú´ëÇÐ Á×¼º°ÀÇ½Ç 10:20~10:40 °³È¸»ç/´ëȸÀåÀλç/Ãà»ç µî ( )
±³À°½Ã°£ 11¿ù 18ÀÏ ¿µ³²´ëÇб³ÀÇ°ú´ëÇÐ Á×¼º°ÀÇ½Ç 10:40~10:55 Oncology session1. Bimodal therapy for bladder preservation in MIBC, is it feasible? ÇÏÀ±¼®(°æºÏÀÇ´ë)
±³À°½Ã°£ 11¿ù 18ÀÏ ¿µ³²´ëÇб³ÀÇ°ú´ëÇÐ Á×¼º°ÀÇ½Ç 10:55~11:10 2. Combined TMT and immunotherapy in urothelial bladder cancer ¹Ú¼ºÂù(¿ï»êÀÇ´ë)
Åä·Ð 11¿ù 18ÀÏ ¿µ³²´ëÇб³ÀÇ°ú´ëÇÐ Á×¼º°ÀÇ½Ç 11:10~11:25 Åä·Ð Á¤½ÂÀÏ(Àü³²ÀÇ´ë)
±³À°½Ã°£ 11¿ù 18ÀÏ ¿µ³²´ëÇб³ÀÇ°ú´ëÇÐ Á×¼º°ÀÇ½Ç 11:25~11:35 Çʼö±³À° ¹× °£È£»ç ¼¼¼Ç1. ´ÙÁ¦³»¼º±Õ ½Ã´ë¿¡¼ ºñ´¢ÀÇÇаúÀÇ ´ëó¹æ¾È °È£¿ø(ÃæºÏÀÇ´ë)
±³À°½Ã°£ 11¿ù 18ÀÏ ¿µ³²´ëÇб³ÀÇ°ú´ëÇÐ Á×¼º°ÀÇ½Ç 11:35~11:45 2. ¾ÈÀüÇÑ ¹æ±¤³»½Ã°æ½Ç °ü¸®¸¦ À§ÇÑ ºñ´¢ÀÇÇаú ÀÇ»çÀÇ ¿ªÇÒ °íÇõÁØ(µ¿¾ÆÀÇ´ë)
±³À°½Ã°£ 11¿ù 18ÀÏ ¿µ³²´ëÇб³ÀÇ°ú´ëÇÐ Á×¼º°ÀÇ½Ç 11:45~11:55 3. ¾ÈÀüÇÑ ¹æ±¤³»½Ã°æ½Ç °ü¸®¸¦ À§ÇÑ °£È£»çÀÇ ¿ªÇÒ ÃÖ¿µ½Å(Ä¥°î°æºÏ´ëÇб³º´¿ø)
Åä·Ð 11¿ù 18ÀÏ ¿µ³²´ëÇб³ÀÇ°ú´ëÇÐ Á×¼º°ÀÇ½Ç 11:55~12:10 Åä·Ð ¿À°æÁø(Àü³²ÀÇ´ë)
½Ä»ç 11¿ù 18ÀÏ ¿µ³²´ëÇб³ÀÇ°ú´ëÇÐ Á×¼º°ÀÇ½Ç 12:10~13:00 ´Üü»çÁø ¹× Á¡½É½Ä»ç ( )
±âŸ 11¿ù 18ÀÏ ¿µ³²´ëÇб³ÀÇ°ú´ëÇÐ Á×¼º°ÀÇ½Ç 13:00~13:30 ºñ´¢ÀÇÇаú ¼±»ý´ÔµéÀ» À§ÇÑ ½ÇÀü °ñÇÁ·¹½¼ ( )
±âŸ 11¿ù 18ÀÏ ¿µ³²´ëÇб³ÀÇ°ú´ëÇÐ Á×¼º°ÀÇ½Ç 13:30~13:50 ÃÑȸ ¹× ±â³äÆÐ ÁõÁ¤ ( )
±³À°½Ã°£ 11¿ù 18ÀÏ ¿µ³²´ëÇб³ÀÇ°ú´ëÇÐ Á×¼º°ÀÇ½Ç 13:50~14:20 Á¤³âÅäÀÓ ¼Ò°í : Robotic surgery in asia and beyond. ¼º°æŹ(µ¿¾ÆÀÇ´ë)
±³À°½Ã°£ 11¿ù 18ÀÏ ¿µ³²´ëÇб³ÀÇ°ú´ëÇÐ Á×¼º°ÀÇ½Ç 14:20~14:50 LUTS/BPH1. Updates on various attempts to overcome OAB: PTNS, intravesical electrical stimulation, radiofrequency ablations, gene therapy ±è¿µ¿í(¿µ³²ÀÇ´ë)
±³À°½Ã°£ 11¿ù 18ÀÏ ¿µ³²´ëÇб³ÀÇ°ú´ëÇÐ Á×¼º°ÀÇ½Ç 14:50~15:15 2. Can MIS replace the conventional BPH surgery (TURP, HoLEP) ÀÌÃæ·Ä(Ãæ³²ÀÇ´ë)
Åä·Ð 11¿ù 18ÀÏ ¿µ³²´ëÇб³ÀÇ°ú´ëÇÐ Á×¼º°ÀÇ½Ç 15:15~15:30 Åä·Ð Á¶¿ø¿(µ¿¾ÆÀÇ´ë)
±³À°½Ã°£ 11¿ù 18ÀÏ ¿µ³²´ëÇб³ÀÇ°ú´ëÇÐ Á×¼º°ÀÇ½Ç 15:30~15:45 Non-surgical aspects of kidney stone1. Why should we treat asymptomatic kidney stone? ±è¿¬ÁÖ(´ë±¸ÆÄƼ¸¶º´¿ø)
±³À°½Ã°£ 11¿ù 18ÀÏ ¿µ³²´ëÇб³ÀÇ°ú´ëÇÐ Á×¼º°ÀÇ½Ç 15:45~16:00 2. Kidney stone and patients¡¯ health-related quality of life ±èÇö¿ì(ºÎ»êÀÇ´ë)
±³À°½Ã°£ 11¿ù 18ÀÏ ¿µ³²´ëÇб³ÀÇ°ú´ëÇÐ Á×¼º°ÀÇ½Ç 16:00~16:15 3. Follow-up strategy and patients¡¯ education for kidney stone ¿ÀÅÂÈÆ(¿ø±¤ÀÇ´ë)
Åä·Ð 11¿ù 18ÀÏ ¿µ³²´ëÇб³ÀÇ°ú´ëÇÐ Á×¼º°ÀÇ½Ç 16:15~16:30 Åä·Ð À̽¼ö(ºÎ»êÀÇ´ë)